Key result
GLS from 2D-STE strongly predicts adverse outcomes across cardiac diseases, especially ACS.
Why the study?
Does Global longitudinal peak systolic strain (GLPSS) predict adverse outcomes in patients with acute coronary syndrome (ACS) with gender-specific differences?
Does Global longitudinal peak systolic strain (GLPSS) predict adverse outcomes in patients with acute coronary syndrome (ACS) with gender-specific differences?
Global longitudinal strain by 2D speckle tracking echocardiography is highlighted as a strong predictor of adverse outcomes in acute coronary syndrome.
GLPSS may refine ACS risk stratification beyond LVEF; leaves open need for prospective validation of gender-specific thresholds.
Global longitudinal strain (GLS) obtained by 2D speckle tracking echocardiography (STE) is a well-established predictor of HF. GLS has been proven to be more reproducible and precise compared to conventional left ventricular ejection fraction (LVEF). Additionally, STE has been advocated as a more sensitive marker for detection of subclinical left ventricular systolic dysfunction Recent studies have shown global longitudinal strain (GLS) obtained from 2D-speckle tracking echocardiography to be a strong predictor of adverse outcomes in several cardiac diseases especially ACS.
No takes yet. Share an insight, caveat, or question.
Abdalla et al. (2022) studied Acute coronary syndrome (ACS). Global longitudinal peak systolic strain (GLPSS) vs. Left ventricular ejection fraction (LVEF) was evaluated on Adverse outcomes. Global longitudinal strain obtained from 2D-speckle tracking echocardiography is a strong predictor of adverse outcomes in several cardiac diseases, especially acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: